C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 31/7088 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) A61P 1/00 (2006.01) C07H 21/00 (2006.01) C07K 14/47 (2006.01) C12Q 1/68 (2006.01) C40B 30/04 (2006.01) C40B 40/06 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2658563
The present invention relates to the ATG16l1 gene and genetic variants associated with Crohn's disease. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to Crohn's disease and/or their response to a particular drug or drugs.
La présente invention concerne le gène ATG1611 et les variants génétiques associés à la maladie de Crohn. En particulier, l'invention concerne les domaines de pharmacogénomique, de diagnostic, de thérapie de patients et l'utilisation d'information d'haplotype génétique pour prédire la susceptibilité d'un sujet à la maladie de Crohn et/ou sa réaction à un médicament ou des médicaments particulier(s).
Belouchi Abdelmajid
Bruat Vanessa
Franke Andre
Hampe Jochen
Keith Tim
Genizon Biosciences Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Prometheus Laboratories Inc.
LandOfFree
Crohn disease susceptibility gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crohn disease susceptibility gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crohn disease susceptibility gene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2078103